ReviewInternational journal of hematology2015
Therapeutic benefits targeting B-cells in chronic graft-versus-host disease.
Hideki Nakasone et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papertrialcites it
ReviewInternational journal of hematology2015
Hideki Nakasone et al.PubMed ↗Publisher ↗
No numbers read from the abstract.